Physician profile
Charles A Odonkor
NPI 1457797755
$80,668.12
in general payments reported to CMS, 2019-2025
18 companies · $51K in 2025
The $51K reported for 2025 was more than what 99% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,748 · 2020: $2,238 · 2021: $814 · 2022: $314 · 2023: $1,053 · 2024: $23K · 2025: $51K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $18K · Consulting Fee: $16K · Food and Beverage: $11K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $30,600.00 |
| Travel and Lodging | $17,948.29 |
| Consulting Fee | $15,687.50 |
| Food and Beverage | $11,318.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $59,785.68 | 2019-2025 | Wavewriter Alpha Prime 16, General - Therapies, Intracept |
| Spr Therapeutics, INC | $9,547.06 | 2023-2025 | Sprint Pns System |
| Abbott Laboratories | $3,496.30 | 2019-2025 | Proclaim, Eterna |
| Saluda Medical Americas, INC. | $2,334.90 | 2025 | Evoke |
| Medtronic, INC. | $1,803.44 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray |
| Mml US, INC. | $1,351.03 | 2023-2025 | Reactiv8 |
| Medtronic USA, INC. | $913.06 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $349.64 | 2024 | Iovera |
| Stimwave Technologies Incorporated | $272.93 | 2019-2020 | |
| Biotronik Nro, INC. | $196.86 | 2024-2025 | Prospera |
| Si-Bone, INC. | $139.90 | 2023-2025 | |
| Curonix LLC | $131.28 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bioventus LLC | $81.82 | 2021 | |
| Vertos Medical, INC. | $79.59 | 2024 | Mild Device Kit |
| Tonix Medicines, INC. | $77.10 | 2025 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $54.18 | 2025 | |
| Nevro Corp. | $34.10 | 2019 | |
| Nalu Medical, INC. | $19.25 | 2024 | Nalu Neurostimulation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Odonkor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.